Sleeve Gastroplasty Combined with the NLRP3 Inflammasome Inhibitor CY-09 Reduces Body Weight, Improves Insulin Resistance and Alleviates Hepatic Steatosis in Mouse Model

被引：0
|
作者：
Kangyue Sun
Jing Wang
Zhixian Lan
Ling Li
Yadong Wang
Aimin Li
Side Liu
Yue Li
机构：
[1] Southern Medical University,Department of Gastroenterology, Nanfang Hospital
[2] The Johns Hopkins School of Medicine,Division of Gastroenterology and Hepatology
来源：
Obesity Surgery | 2020年 / 30卷
关键词：
Endoscopic sleeve gastroplasty; NAFLD; NLRP3 inflammasome; CY-09;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：3435 / 3443
页数：8
相关论文
共 17 条
  • [1] Sleeve Gastroplasty Combined with the NLRP3 Inflammasome Inhibitor CY-09 Reduces Body Weight, Improves Insulin Resistance and Alleviates Hepatic Steatosis in Mouse Model
    Sun, Kangyue
    Wang, Jing
    Lan, Zhixian
    Li, Ling
    Wang, Yadong
    Li, Aimin
    Liu, Side
    Li, Yue
    OBESITY SURGERY, 2020, 30 (09) : 3435 - 3443
  • [2] NLRP3 inflammasome inhibitor CY-09 reduces hepatic steatosis in experimental NAFLD mice
    Wang, Xianfei
    Sun, Kangyue
    Zhou, Youlian
    Wang, Hong
    Zhou, Yongjian
    Liu, Side
    Nie, Yuqiang
    Li, Yue
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2021, 534 : 734 - 739
  • [3] CY-09 Alleviates the Depression-like Behaviors via Inhibiting NLRP3 Inflammasome-Mediated Neuroinflammation in Lipopolysaccharide-Induced Mice
    Wang, Yu
    Liu, Yi-Jie
    Zhang, Man -Man
    Zhou, Han
    Gao, Yi-Han
    Cheng, Wen-Jing
    Ye, Zi-Wei
    Yuan, Zhong-Yu
    Xu, Guang-Hui
    Li, Cheng-Fu
    Yi, Li-Tao
    ACS CHEMICAL NEUROSCIENCE, 2022, 13 (23): : 3291 - 3302
  • [4] Uric Acid Regulates Hepatic Steatosis and Insulin Resistance Through the NLRP3 Inflammasome Dependent Mechanism
    Wan, Xingyong
    Xu, Chengfu
    Lu, Chao
    Zhu, Huatuo
    Yu, Chaohui
    Li, Youming
    GASTROENTEROLOGY, 2015, 148 (04) : S1053 - S1053
  • [5] Uric acid regulates hepatic steatosis and insulin resistance through the NLRP3 inflammasome-dependent mechanism
    Wan, Xingyong
    Xu, Chengfu
    Lin, Yiming
    Lu, Chao
    Li, Dejian
    Sang, Jianzhong
    He, Haijian
    Liu, Xiao
    Li, Youming
    Yu, Chaohui
    JOURNAL OF HEPATOLOGY, 2016, 64 (04) : 925 - 932
  • [6] NLRP3 inflammasome inhibition with MCC950 improves insulin sensitivity and inflammation in a mouse model of frontotemporal dementia
    Hull, Claire
    Dekeryte, Ruta
    Buchanan, Heather
    Kamli-Salino, Sarah
    Robertson, Avril
    Delibegovic, Mirela
    Platt, Bettina
    NEUROPHARMACOLOGY, 2020, 180
  • [7] GPAT3 deficiency alleviates insulin resistance and hepatic steatosis in a mouse model of severe congenital generalized lipodystrophy
    Gao, Mingming
    Liu, Lin
    Wang, Xiaowei
    Mak, Hoi Yin
    Liu, George
    Yang, Hongyuan
    HUMAN MOLECULAR GENETICS, 2020, 29 (03) : 432 - 443
  • [8] Hyperhomocysteinemia activates NLRP3 inflammasome to cause hepatic steatosis and insulin resistance via MDM2-mediated ubiquitination of HSF1
    Xiang, Wenjing
    Yang, Yang
    Weng, Liangkun
    Ye, Zhiming
    Ding, Ping
    Li, Huayu
    Sun, Jia
    Zeng, Cheng
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2023, 118
  • [9] Novel NLRP3 Inflammasome Inhibitor OLT1177 Reduces Infarct Size in a Mouse Model of Myocardial Ischemia Reperfusion Injury
    Toldo, Stefano
    Mauro, Adolfo G.
    Marchetti, Carlo
    Mezzaroma, Eleonora
    Van Tassell, Benjamin
    Skouras, Damaris
    La Neve, Federica
    Dinarello, Charles
    Abbate, Antonio
    CIRCULATION, 2017, 136
  • [10] AN INHIBITOR OF THE NLRP3 INFLAMMASOME 16673-34-0 REDUCES INFARCT SIZE IN A MOUSE MODEL OF MYOCARDIAL ISCHEMIA REPERFUSION INJURY
    Marchetti, Carlo
    Toldo, Stefano
    Chojnacki, Jeremy
    Mezzaroma, Eleonora
    Federici, Massimo
    Voelkel, Norbert F.
    Van Tassell, Benjamin W.
    Zhang, Shijun
    Abbate, Antonio
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 63 (12) : A37 - A37
12